More News

17 May 2018 Intellia Therapeutics Announces WT1 as Its First Cell Therapy Target, Following Presentation of Early Data at the American Society of Gene and Cell Therapy 21st Annual Meeting
16 May 2018 Fate Therapeutics and Memorial Sloan Kettering Cancer Center Expand Scope of License Agreement to include Gene-edited T-cell Immunotherapies
15 May 2018 TapImmune and Marker Therapeutics Announce Entry into Merger Agreement, Creating a Transformational Immuno-Oncology Platform
15 May 2018 Kite Announces New Worldwide Facilities and Expanded Collaboration With National Cancer Institute to Support Cell Therapy Pipeline
15 May 2018 Zymeworks and Daiichi Sankyo Expand Immuno-Oncology Collaboration Focused on Bispecific Antibodies
14 May 2018 Lilly to Acquire AurKa Pharma
14 May 2018 Medigene significantly expands TCR alliance with bluebird bio in cancer immunotherapy
14 May 2018 Catalent Biologics and Valerius Biopharma to Collaborate on Manufacture of Specialty Biosimilars
10 May 2018 Lilly Announces Agreement To Acquire ARMO BioSciences
10 May 2018 FORMA Therapeutics and the University of Oxford Announce Multi-Year Collaboration to Advance the Development of Deubiquitinating Enzyme (DUB) Inhibitors for the Treatment of Neurodegenerative Diseases
10 May 2018 Aquinox and Astellas Announce Exclusive Licensing Agreement for Rosiptor in the Asia-Pacific Region Including Japan
09 May 2018 Lodo Therapeutics Corporation Forms Multi-Target Strategic Collaboration with Genentech
09 May 2018 Provention Bio Announces Agreements with MacroGenics for Two Clinical-Stage Assets for the Treatment of Autoimmune Disorders
08 May 2018 Atara Biotherapeutics Expands T-Cell Immunotherapy Collaboration to Advance Next-Generation CAR T Technologies in Oncology, Autoimmune and Other Diseases
08 May 2018 Proposed Acquisition of Shire plc by Takeda
07 May 2018 Aptose Exercises Early Option for CG-806 License From CrystalGenomics
07 May 2018 LipimetiX Development Announces Sub-License of Apo E Mimetic Peptide Platform to Anji Pharma, China
04 May 2018 Sarepta Therapeutics Announces Partnership with Myonexus Therapeutics for the Advancement of Multiple Gene Therapy Programs Aimed at Treating Distinct Forms of Limb-Girdle Muscular Dystrophies
04 May 2018 Exelixis and Invenra Enter Into Collaboration to Discover and Develop Novel Biologics to Treat Cancer
04 May 2018 Moderna and Merck Expand mRNA Cancer Vaccines Collaboration
03 May 2018 Third Rock Ventures Launches Casma Therapeutics with $58.5 Million Investment to Harness the Cellular Process of Autophagy to Develop Breakthrough Therapies
03 May 2018 Ferring Signs Global Agreement to Commercialise Novel Gene Therapy for Bladder Cancer Patients
02 May 2018 Bactevo Enters Drug Discovery Agreement with Boehringer Ingelheim
02 May 2018 Janssen to Acquire BeneVir Biopharm to Advance Immunotherapy Regimens
02 May 2018 Merck KGaA, Darmstadt, Germany to Develop Abituzumab in Metastatic Colorectal Cancer with SFJ Pharmaceuticals Group

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2017 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up